|
|
|
Insider
Information: |
Buchi J Kevin |
Relationship: |
Director |
City: |
West Chester |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
174,797 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$296,297 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
174,797 |
|
|
Total
Value |
$296,297 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
5
|
0
|
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
Percentage
Gain/Loss : |
-63.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cephalon Inc |
CEPH |
Chief Executive Office... |
2011-10-14 |
0 |
2011-10-14 |
0 |
Premium* |
|
Encysive Pharmaceuticals Inc |
ENCY |
Director |
2008-04-01 |
0 |
2007-04-02 |
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Director |
2015-06-23 |
23,772 |
|
0 |
Premium* |
|
Impax Laboratories Inc |
IPXL |
Director |
2018-05-04 |
0 |
2016-11-23 |
0 |
Premium* |
|
Alaunos Therapeutics |
TCRT |
Director |
2021-03-04 |
4,167 |
2021-03-04 |
0 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
Ampio Pharmaceuticals Inc |
AMPE |
Director |
2023-06-09 |
146,858 |
2023-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CEPH |
Cephalon Inc |
Exec. V.P., CFO |
|
2008-12-19 |
4 |
D |
$77.50 |
$125,240 |
D/D |
(1,616) |
75,796 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. Vice President & CFO |
|
2007-12-03 |
4 |
D |
$74.50 |
$120,467 |
D/D |
(1,617) |
92,837 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. Vice President & CFO |
|
2007-12-19 |
4 |
D |
$73.90 |
$119,496 |
D/D |
(1,617) |
82,583 |
0 |
- |
|
CEPH |
Cephalon Inc |
Chief Operating Officer |
|
2010-12-20 |
4 |
D |
$64.67 |
$104,571 |
D/D |
(1,617) |
109,146 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. V.P., CFO |
|
2008-12-16 |
4 |
D |
$76.35 |
$148,043 |
D/D |
(1,939) |
77,412 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Director |
|
2007-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,106 |
3,489 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Director |
|
2007-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,483 |
5,972 |
0 |
- |
|
CEPH |
Cephalon Inc |
Chief Executive Officer |
|
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,592) |
0 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. Vice President and CFO |
|
2006-12-18 |
4 |
D |
$71.17 |
$194,436 |
D/D |
(2,732) |
79,734 |
0 |
- |
|
CEPH |
Cephalon Inc |
Chief Operating Officer |
|
2010-12-13 |
4 |
D |
$62.95 |
$203,580 |
D/D |
(3,234) |
80,763 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Director |
|
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,281 |
11,301 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Director |
|
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,281) |
0 |
0 |
- |
|
CEPH |
Cephalon Inc |
Exec. Vice President & CFO |
|
2007-12-17 |
4 |
D |
$74.59 |
$265,317 |
D/D |
(3,557) |
84,200 |
0 |
- |
|
CEPH |
Cephalon Inc |
Sr. Vice President & CFO |
|
2003-12-19 |
4 |
OE |
$13.00 |
$48,750 |
D/D |
3,750 |
72,052 |
|
- |
|
TCRT |
Alaunos Therapeutics |
Director |
|
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
4,167 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,666 |
4,666 |
0 |
- |
|
DRNA |
Dicerna Pharmaceuticals I... |
Director |
|
2021-12-28 |
4 |
D |
$38.25 |
$178,475 |
D/D |
(4,666) |
0 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Director |
|
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,281 |
11,253 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Director |
|
2016-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,020 |
8,020 |
0 |
- |
|
IPXL |
Impax Laboratories Inc |
Director |
|
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,020) |
0 |
0 |
- |
|
CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
|
2005-11-08 |
4 |
OE |
$31.00 |
$260,400 |
D/D |
8,400 |
79,980 |
|
- |
|
CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
|
2005-11-08 |
4 |
S |
$46.51 |
$390,660 |
D/D |
(8,400) |
71,580 |
|
- |
|
STML |
Stemline Therapeutics Inc |
Director |
|
2015-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,772 |
0 |
- |
|
ENCY |
Encysive Pharmaceuticals ... |
Director |
|
2008-04-01 |
4 |
D |
$2.35 |
$26,445 |
D/D |
(11,253) |
0 |
0 |
- |
|
CEPH |
Cephalon Inc |
Sr. Vice President and CFO |
|
2003-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
68,302 |
|
- |
|
72 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|